India's Richest People 2026 edition · 2 directors · Source: Hurun India
- #813 TT Raghunathan ₹3,800 Cr
- #1,427 Mukund Thiruvallur Thattai ₹1,500 Cr
Market Cap
₹1,292 Cr
TTKHLTCARE · NSE
Share Price
₹912.45
-0.20% today
Revenue
₹889 Cr
FY 2025-26 · +7.6% YoY
EBITDA
₹22.10 Cr
Margin 2.5%
Net Profit
₹68.68 Cr
FY 2025-26 · -3.5% YoY
P/E (TTM)
17.6x
P/B 1.0x
ROE
6.0%
ROCE 7.7%
Debt / Equity
0.02
Interest cover 22.0x
About TTK Healthcare Limited
Data last updated:
TTK Healthcare Limited is a public limited company based in Chennai, Tamil Nadu, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 21 May 1958 and has been in existence for over 68 years.
Its director TT Raghunathan is #813 among India's richest people (2026). Its director Mukund Thiruvallur Thattai is #1,427 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN L24231TN1958PLC003647. Its GSTIN is 33AABCT3312J1ZP (Tamil Nadu). The company holds 25 GST registrations, of which 24 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 507747 and NSE: TTKHLTCARE.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹14.13 Cr. It was formerly known as Orient Pharma Pvt Ltd and Ttk Healthcare Private Limited. It is led by directors including Subramaniam Kalyanaraman (Managing Director) and Raghunathan Thiruvallur Thattai (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at No.6 Cathedral Road, Chennai, Tamil Nadu, India – 600086.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹888.58 Cr, a growth of 7.6% compared to the previous year. For the same year it recorded a net profit of ₹68.68 Cr (net margin 7.7%) and EBITDA of ₹22.1 Cr (EBITDA margin 2.5%). The net worth stands at ₹1,114.85 Cr (up 4.7% YoY). Total assets are valued at ₹1,144.91 Cr (up 4.8% YoY).
The company has about 985 employees on its provident fund (EPFO) records.
The company is associated with 4 brands: Love Depot, Woodwards, TTK Healthcare Ltd and Ttk Healthcare Limited. As per MCA filings, the company has open charges of ₹40.25 Cr and satisfied charges of ₹49.9 Cr on record. Court records list 396 cases involving the company, including 213 filed by the company and 183 filed against it; 36 cases are pending. The company has 32 deals on record (28 market trades, 2 funding rounds, 1 acquisition), with disclosed funding of ₹17.31 Cr; the latest was in March 2025. The company has 4 MSME Form 1 returns on record between 2018 and 2019, listing 167 overdue payments to 42 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ttkhealthcare.com.
Company details
CIN L24231TN1958PLC003647
Registration Number 003647
Incorporation Date 21 May 1958
ROC Chennai
Listing Status Listed - Listed on NSE (TTKHLTCARE); Listed on BSE (507747)
Company Status Active
Date of Last AGM 25 July 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
Name history
TTK Healthcare has undergone 4 name changes throughout its history. The current legal name is Ttk Healthcare Limited.
| Company Name | Status |
|---|---|
| TTK Healthcare Limited | Current |
| Orient Pharma Pvt Ltd | Previous |
| Ttk Healthcare Private Limited | Previous |
| Ttk Pharma Pvt Ltd | Previous |
| Ttk Pharma Ltd | Previous |
CIN history
TTK Healthcare has one previous CIN (Corporate Identification Number): L24231TN1958PTC003647. The current CIN is L24231TN1958PLC003647, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24231TN1958PLC003647 | Current |
| L24231TN1958PTC003647 | Previous |
Key People
Subramaniam Kalyanaraman Managing Director Raghunathan Thiruvallur Thattai Whole-Time Director Vijayaraghavachari Ranganathan Director Recognitions & Rankings of TTK Healthcare
Contact details
TTK Healthcare Limited's registered office is in Chennai, Tamil Nadu. Its website is ttkhealthcare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.6 Cathedral Road, Chennai, Tamil Nadu, India – 600086
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of TTK Healthcare Limited, buy the company report.
Comprehensive company report
TTK Healthcare Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
TTK Healthcare operates multiple associated brands including Love Depot, Woodwards, and TTK Healthcare Ltd. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online retailer of adult toys, accessories, and pleasure products in India. | lovedepot.com | |
| Gripe water for infant digestive relief and related baby care services in India. | woodwards.in | |
| Provider of consumer products & pharmaceutical formulations | ttkhealthcare.com | |
| Orthopedic products, medical devices, and healthcare services in Chennai. | ttkortho.com |
Business activity
The main business activity of TTK Healthcare is manufacturing. 4 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C1 | Food, beverages and tobacco products | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products | |
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of TTK Healthcare Limited, buy the company report.
Financials of TTK Healthcare Limited
FY 2025-26 filings availableTTK Healthcare Limited reported revenue of ₹888.58 Cr (up 7.6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹889 Cr
+7.6% YoY
EBITDA
₹22.10 Cr
-36.5% YoY
Profit After Tax
₹68.68 Cr
-3.5% YoY
Net Worth
₹1,115 Cr
+4.7% YoY
Total Assets
₹1,145 Cr
+4.8% YoY
Total Debt
₹24.37 Cr
+0.6% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 889 | 826 | 753 | 725 | 599 | 476 | 646 |
| Revenue growth | +7.6% | +9.7% | +3.8% | +21.0% | +25.9% | -26.3% | - |
| EBITDA | 22.10 | 34.82 | 37.32 | 31.35 | 21.83 | 19.32 | 28.30 |
| EBITDA margin | +2.5% | +4.2% | +5.0% | +4.3% | +3.6% | +4.1% | +4.4% |
| Profit before tax | 82.56 | 108 | 84.11 | 657 | 47.91 | 32.28 | 19.43 |
| Net profit | 68.68 | 71.20 | 62.85 | 640 | 39.49 | 40.31 | 12.35 |
| Net profit margin | +7.7% | +8.6% | +8.4% | +88.2% | +6.6% | +8.5% | +1.9% |
| EPS (₹) | 46.48 | 57.79 | 44.47 | 452.72 | 29.43 | 32.87 | 8.72 |
| Balance sheet | |||||||
| Total assets | 1,145 | 1,093 | 1,027 | 985 | 359 | 324 | 288 |
| Net worth | 1,115 | 1,065 | 1,001 | 953 | 330 | 295 | 249 |
| Total debt | 24.37 | 24.22 | 22.81 | 27.33 | 22.21 | 19.15 | 29.84 |
| Cash & bank | 633 | 786 | 775 | 847 | 274 | 228 | 132 |
| Net working capital | 1,034 | 915 | 898 | 881 | 249 | 204 | 155 |
| Cash flow | |||||||
| Cash from operations | (21.15) | (3.98) | (4.94) | (24.81) | 45.00 | 96.42 | 19.84 |
| Cash from investing | 51.58 | 20.10 | 28.49 | 31.69 | (29.56) | (77.24) | (13.30) |
| Cash from financing | (17.56) | (18.08) | (21.91) | (12.43) | (10.13) | (17.16) | (10.17) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 233 | 258 | 218 | 209 | 204 | 226 | 190 | 205 |
| Revenue growth (YoY) | +14.6% | +13.8% | +14.5% | +2.2% | +2.6% | +8.9% | - | - |
| Other income | 267 | 16.79 | 21.27 | 17.43 | 19.01 | 17.94 | 18.69 | 17.84 |
| Total expenses | 230 | 243 | 207 | 210 | 198 | 224 | 184 | 197 |
| EBITDA | 3.74 | 14.74 | 11.02 | (0.44) | 5.34 | 2.68 | 6.14 | 7.69 |
| EBITDA margin | +1.6% | +5.7% | +5.1% | -0.2% | +2.6% | +1.2% | +3.2% | +3.8% |
| Depreciation | 2.16 | 2.14 | 2.14 | 2.22 | 2.21 | 2.19 | 2.17 | 2.11 |
| Interest | 0.59 | 0.53 | 0.64 | 0.68 | 0.84 | 0.77 | 0.90 | 0.82 |
| Profit before tax | 268 | 28.86 | 29.51 | 14.09 | 21.30 | 17.66 | 21.76 | 22.60 |
| Tax | 44.96 | 7.58 | 7.76 | 3.55 | 0.91 | 4.65 | 5.61 | 5.86 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 03 Nov 2026
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 233 | 258 | 218 | 209 | 204 | 226 | 190 | 205 |
| Revenue growth (YoY) | +14.6% | +13.8% | +14.5% | +2.2% | +2.6% | +8.9% | - | - |
| Other income | 267 | 16.79 | 21.27 | 17.43 | 19.01 | 17.94 | 18.69 | 17.84 |
| Total expenses | 230 | 243 | 207 | 210 | 198 | 224 | 184 | 197 |
| EBITDA | 3.74 | 14.74 | 11.02 | (0.44) | 5.34 | 2.68 | 6.14 | 7.69 |
| EBITDA margin | +1.6% | +5.7% | +5.1% | -0.2% | +2.6% | +1.2% | +3.2% | +3.8% |
| Depreciation | 2.16 | 2.14 | 2.14 | 2.22 | 2.21 | 2.19 | 2.17 | 2.11 |
| Interest | 0.59 | 0.53 | 0.64 | 0.68 | 0.84 | 0.77 | 0.90 | 0.82 |
| Profit before tax | 268 | 28.86 | 29.51 | 14.09 | 21.30 | 17.66 | 21.76 | 22.60 |
| Tax | 44.96 | 7.58 | 7.76 | 3.55 | 0.91 | 4.65 | 5.61 | 5.86 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 889 | 826 | 753 | 725 | 599 | 476 | 646 |
| Revenue growth | +7.6% | +9.7% | +3.8% | +21.0% | +25.9% | -26.3% | - |
| Other income | 72.15 | 85.16 | 62.61 | 643 | 41.90 | 27.69 | 8.78 |
| Total expenses | 866 | 791 | 715 | 694 | 577 | 457 | 617 |
| Employee cost | 165 | 151 | 133 | 123 | 103 | 93.70 | 144 |
| EBITDA | 22.10 | 34.82 | 37.32 | 31.35 | 21.83 | 19.32 | 28.30 |
| EBITDA margin | +2.5% | +4.2% | +5.0% | +4.3% | +3.6% | +4.1% | +4.4% |
| Depreciation | 8.76 | 8.33 | 13.06 | 12.81 | 12.58 | 13.02 | 14.38 |
| Interest | 2.93 | 3.32 | 2.76 | 5.24 | 3.24 | 1.71 | 3.27 |
| Profit before tax | 82.56 | 108 | 84.11 | 657 | 47.91 | 32.28 | 19.43 |
| Tax | 16.88 | 26.67 | 21.28 | 16.97 | 6.33 | (14.16) | 7.11 |
| Net profit | 68.68 | 71.20 | 62.85 | 640 | 39.49 | 40.31 | 12.35 |
| Net profit margin | +7.7% | +8.6% | +8.4% | +88.2% | +6.6% | +8.5% | +1.9% |
| EPS (₹) | 46.48 | 57.79 | 44.47 | 452.72 | 29.43 | 32.87 | 8.72 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 14.13 | 14.13 | 14.13 | 14.13 | 14.13 | 14.13 | 14.13 |
| Reserves & surplus | 1,101 | 1,051 | 987 | 939 | 316 | 281 | 235 |
| Shareholders' funds (net worth) | 1,115 | 1,065 | 1,001 | 953 | 330 | 295 | 249 |
| Secured loans | 21.90 | 21.94 | 21.47 | 25.53 | 20.38 | 17.60 | 28.13 |
| Unsecured loans | 2.47 | 2.28 | 1.34 | 1.80 | 1.83 | 1.55 | 1.71 |
| Total debt | 24.37 | 24.22 | 22.81 | 27.33 | 22.21 | 19.15 | 29.84 |
| Total liabilities | 1,145 | 1,093 | 1,027 | 985 | 359 | 324 | 288 |
| Assets | |||||||
| Gross block | 182 | 183 | 178 | 164 | 165 | 159 | 149 |
| Net block | 72.68 | 80.90 | 74.81 | 71.19 | 80.28 | 85.35 | 88.64 |
| Capital work in progress | 1.37 | 0.08 | 0.79 | 2.79 | 0.19 | 0.45 | 8.77 |
| Investments | 8.66 | 11.22 | 12.56 | 12.85 | 15.13 | 13.17 | 8.75 |
| Inventories | 109 | 109 | 96.99 | 84.51 | 78.92 | 70.30 | 71.64 |
| Sundry debtors | 111 | 90.53 | 86.44 | 92.10 | 53.58 | 59.78 | 76.77 |
| Cash & bank balances | 633 | 786 | 775 | 847 | 274 | 228 | 132 |
| Loans & advances | 365 | 118 | 119 | 42.30 | 42.49 | 17.10 | 17.22 |
| Total current assets | 1,218 | 1,104 | 1,077 | 1,066 | 448 | 375 | 298 |
| Total current liabilities | 184 | 188 | 180 | 185 | 200 | 171 | 143 |
| Net working capital | 1,034 | 915 | 898 | 881 | 249 | 204 | 155 |
| Total assets | 1,145 | 1,093 | 1,027 | 985 | 359 | 324 | 288 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 9.01 | 10.96 | 9.32 | 14.86 | 9.55 | 7.53 | 11.15 |
| Net cash from operating activities | (21.15) | (3.98) | (4.94) | (24.81) | 45.00 | 96.42 | 19.84 |
| Net cash from investing activities | 51.58 | 20.10 | 28.49 | 31.69 | (29.56) | (77.24) | (13.30) |
| Net cash from financing activities | (17.56) | (18.08) | (21.91) | (12.43) | (10.13) | (17.16) | (10.17) |
| Net change in cash | 12.88 | (1.95) | 1.64 | (5.54) | 5.31 | 2.03 | (3.63) |
| Closing cash | 633 | 786 | 775 | 847 | 274 | 228 | 132 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +7.6% | +9.7% | +3.8% | +21.0% | +25.9% | -26.3% | - |
| EBITDA growth | -36.5% | -6.7% | +19.0% | +43.6% | +13.0% | -31.7% | - |
| PBT growth | -23.8% | +28.8% | -87.2% | +1270.7% | +48.4% | +66.1% | -50.5% |
| Net income growth | -3.5% | +13.3% | -90.2% | +1520.3% | -2.0% | +226.4% | - |
| Revenue CAGR (3Y) | +7.0% | +11.3% | +16.5% | +3.9% | -1.5% | -6.2% | +7.0% |
| EBITDA CAGR (3Y) | -11.0% | +16.8% | +24.5% | +3.5% | -23.9% | -23.1% | -9.7% |
| Profitability & leverage | |||||||
| Net income margin | +7.4% | +9.9% | +8.4% | +88.2% | +6.9% | +9.8% | +1.9% |
| Return on capital employed | +7.7% | +9.3% | +8.7% | +10.0% | +7.6% | +5.4% | +8.0% |
| Return on net worth | +6.1% | +6.9% | +6.5% | +100.4% | +12.8% | +15.1% | +5.0% |
| Debt / equity | 0.02 | 0.02 | 0.03 | 0.04 | 0.07 | 0.09 | 0.12 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 21.96 | 12.53 | 11.38 | 28.26 | 35.03 | 27.14 | 23.49 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 4.99 | 4.69 | 4.52 | 4.53 | 3.81 | 3.19 | 4.55 |
| Inventory turnover | 8.18 | 8.03 | 8.30 | 8.87 | 8.03 | 6.71 | 10.17 |
| Debtors turnover | 8.83 | 9.33 | 8.43 | 9.95 | 10.57 | 6.97 | 8.23 |
| EPS (₹) | 46.48 | 57.79 | 44.47 | 452.72 | 29.43 | 32.87 | 8.72 |
| Dividend per share (₹) | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 6.00 | 3.00 |
| Book value per share (₹) | 785.85 | 750.61 | 705.23 | 671.59 | 230.16 | 205.40 | 173.09 |
To see the full year-wise statements and ratios of TTK Healthcare Limited, buy the company report.
Board of directors of TTK Healthcare Limited
TTK Healthcare has 10 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghunathan Thiruvallur Thattai Also directs: TTK Property Services Private Limited, TTK Services Private Limited, TTK Prestige Limited and 1 more | Whole-Time Director | 31 Dec 1998 | 27 Years 10 Months | Current |
| Vijayaraghavachari Ranganathan Also directs: TTK Prestige Limited, Nitta Gelatin India Limited | Director | 01 Jun 2019 | 7 Years 5 Months | Current |
| Subramaniam Kalyanaraman Also directs: Packwell Packaging Products Limited | Managing Director | 22 Aug 2014 | 12 Years 2 Months | Current |
| Rajiv Tulshan Also directs: Varun Eximp Private Limited, Kanishka Enterprises Limited, Iso-Therm Cargo Products Private Limited and 1 more | Director | 30 Nov 1984 | 41 Years 11 Months | Current |
| Krishnamurthy Shankaran | Director | 09 Oct 2000 | 26 Years 0 Months | Current |
| Mukund Thiruvallur Thattai Also directs: TTK Prestige Limited, TTK Partners LLP | Director | 09 Sep 2022 | 4 Years 1 Months | Current |
Showing 6 of 10 current directors. View all directors
Auditor
TTK Healthcare Limited is audited by PKF SRIDHAR & SANTHANAM LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PKF SRIDHAR & SANTHANAM LLP | FY 2024 | 003990S/S200018 |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 74.60%, foreign institutional investors hold 1.90%, domestic institutional investors hold 2.10% and retail and other public shareholders hold 21.40%.
Sep 2026
QUARTER
74.60% Promoters
2.10% DII (Domestic Institutional)
1.90% FII (Foreign Institutional)
21.40% Retail & Others
Promoter holding - history
Now 74.60% · Sep 2026High 74.60% · Dec 2025Low 74.60% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 74.60% | 74.60% | 74.60% | 74.60% |
| Public | 25.40% | 25.40% | 25.40% | 25.40% |
Charges & borrowings
Open charges
₹40.25 Cr
Satisfied charges
₹49.9 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Apr 2018 | 100176375 | Others | ₹13 Cr | Open | |
| 27 Aug 1997 | 80042390 | Corporation Bank | ₹27.25 Cr | Open | |
| 19 Dec 2014 | 10539884 | Commonwealth Bank of Australia | ₹20 Cr | Satisfied | |
| 20 Sep 2004 | 80037391 | Uti Bank Limited | ₹3.75 Cr | Satisfied | |
| 25 Aug 2001 | 80018064 | Maersk Medical as | ₹1 Cr | Satisfied |
To see the full charge records of TTK Healthcare Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
TTK Healthcare Limited has 32 deals on record (28 market trades, 2 funding rounds, 1 acquisition), with disclosed funding of ₹17.31 Cr; the latest was in March 2025.
Total deals
32
Market trades
28
Funding rounds
2
Acquisition
1
Secondary share transfer
1
Disclosed funding
₹17.31 Cr
Deals on record (5 of 32)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Market trade | ₹8.6 Cr | Seller: Uno Metals Ltd |
| Jul 2024 | Market trade | ₹15.03 Cr | Buyer: Uno Metals Ltd Seller: Clubmillionaire Financial Services Private Limited |
| Mar 2022 | Acquisition | ₹805 Cr | Buyer: BSV Pharma Private Limited Seller: TTK Healthcare Limited |
| Mar 2018 | Funding round | ₹6.36 Cr | Investors: MCap Fund Advisors, 3 individuals |
| Dec 2012 | Market trade | ₹9.65 Cr | Buyer: Crosseas Capital Markets Private Limited Seller: Crosseas Capital Markets Private Limited |
To see the full deal history of TTK Healthcare Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
TTK Healthcare Limited has 396 court cases on record: 213 filed by TTK Healthcare, 183 filed against it. 36 cases are pending and 360 are disposed.
Total cases
396
Filed by the company
213
Filed against the company
183
Pending
36
Disposed
360
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 203 | 70 | 19 |
| District courts | 188 | 111 | 16 |
| Supreme Court | 5 | 2 | 1 |
Cases on record (5 of 396)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Court case (REV.APPL) | Filed by the company against Packwell Packaging Products Limited and 1 other | Disposed |
| Madras High Court | Court case (REV.APPL) | Filed by the company against TTK Protective Devices Limited and 2 others | Disposed |
| High Court | Appeal | Filed against the company by Godrej Agrovet Ltd M/S.Rahul Balaji, ,Vishnu Mohan,B. Madhan Babu | Disposed |
| District court, Chennai, Tamil Nadu | Civil suit | Filed by the company against Indhu Corrugated Packaging Pvt Ltd and 1 other | Disposed |
| High Court, TAMIL NADU | Appeal | Filed against the company by Godrej Agrovet Limited | Disposed |
To see the full case history of TTK Healthcare Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
TTK Healthcare Limited was last rated by Icra on 30 Mar 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 30 Mar 2022 |
To see the full credit ratings and regulatory alerts of TTK Healthcare Limited, buy the company report.
MSME payment delays
TTK Healthcare Limited has 4 MSME Form 1 returns on record between 2018 and 2019, listing 167 overdue payments to 42 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 42)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Pondchy Pharmaceuticals | |||
| Hateme Plastic Industries |
To see the full MSME payment records of TTK Healthcare Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
TTK Healthcare Limited has a workforce of 985 employees on its EPFO records as of Apr 06, 2024, across 3 active EPFO establishments.
Employee count
985
Active EPFO establishments
3
Employee growth
-17.37%
GST
TTK Healthcare has 25 GST registrations: 24 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
25
Active
24
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCT3312J1ZP | Tamil Nadu | Active | 01 Jul 2017 |
| 33AABCT3312J2ZO | Tamil Nadu | Active | 27 Jul 2017 |
| 03AABCT3312J1ZS | Punjab | Active | 01 Jul 2017 |
| 04AABCT3312J1ZQ | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of TTK Healthcare Limited, buy the company report.
Recent activity
TTK Healthcare Limited has 32 board changes on record since 1984: 22 appointments and 10 cessations. The latest: Vaithianathan Sundaresan was appointed as Director on 22 Dec 2025.
Filing
Ttk Healthcare Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Chennai.
Appointed
Vaithianathan Sundaresan was appointed as Director.
AGM
Ttk Healthcare Limited last Annual general meeting of members was held on 25 Jul 2025 as per latest MCA records.
Ceased
Sundaram Balasubramanian ceased to be Director.
Appointed
Subashree Anantkrishnan was appointed as Director.
Appointed
Hastha Shivaramakrishnan was appointed as Director.
Ceased
Girish Rao ceased to be Director.
Appointed
Murali Neelakantan was appointed as Director.
Ceased
Vandana Walvekar Ramchandra ceased to be Director.
Appointed
Mukund Thiruvallur Thattai was appointed as Director.
Ceased
Thiruvallur Thattai Jagannathan ceased to be Director.
Ceased
Bhalachandra Narayan Bhagwat ceased to be Director.
52 earlier events are in the company report.
News
TTKHLTCARE: Q2 EBITDA 37M RUPEES VS 53.3M (YOY); Q2 EBITDA MARGIN 1.6% VS 2.62% (YOY)
TTKHLTCARE: Q2 SL PBT 197M RUPEES VS 213M (YOY); CO HAS AN EXCEPTIONAL ITEM OF 2.5B RUPEES
TTKHLTCARE: Q2 REVENUE 2.33B RUPEES VS 2B (YOY)
Frequently asked questions
TTK Healthcare is an active public limited company based in Chennai, Tamil Nadu, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 21 May 1958 (68+ years old) and is registered under CIN L24231TN1958PLC003647. Listed on BSE: 507747 and NSE: TTKHLTCARE.
TTK Healthcare reported revenue of ₹888.58 Cr for FY 2025-26 (up 7.6% YoY) based on standalone financials.
TTK Healthcare has 10 current directors:
- Subramaniam Kalyanaraman - Managing Director
- Raghunathan Thiruvallur Thattai - Whole-Time Director
- Vijayaraghavachari Ranganathan - Director
- Rajiv Tulshan - Director
- Krishnamurthy Shankaran - Director
- Mukund Thiruvallur Thattai - Director
- Subashree Anantkrishnan - Director
- Hastha Shivaramakrishnan - Director
- Murali Neelakantan - Director
- Vaithianathan Sundaresan - Director
The latest financial statements of TTK Healthcare on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of TTK Healthcare is 33AABCT3312J1ZP, registered in Tamil Nadu. The company has 25 GST registrations in all, of which 24 are active and 1 is cancelled or inactive. Other active GSTINs include 33AABCT3312J2ZO (Tamil Nadu), 03AABCT3312J1ZS (Punjab), 04AABCT3312J1ZQ (Chandigarh).
The CIN (Corporate Identification Number) of TTK Healthcare is L24231TN1958PLC003647. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. TTK Healthcare is a listed company as per MCA records. Its shares are listed on both BSE (code: 507747) and NSE (symbol: TTKHLTCARE).
TTK Healthcare has 396 court cases on record: 213 filed by the company and 183 filed against it. 36 are pending. Most are in the high courts.
TTK Healthcare was incorporated on 21 May 1958, making it 68+ years old. It is registered with the Registrar of Companies, Chennai.
TTK Healthcare has 32 deals on record (28 market trades, 2 funding rounds, 1 acquisition), with disclosed funding of ₹17.31 Cr; the latest was in March 2025.
Vaithianathan Sundaresan was appointed as Director on 22 Dec 2025. Sundaram Balasubramanian ceased to be Director on 27 Mar 2025. Subashree Anantkrishnan was appointed as Director on 24 Jan 2025. TTK Healthcare has 32 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages